85 related articles for article (PubMed ID: 17599124)
1. [Treatment of opiate-dependent patients in a general practice].
Haarr D; Nessa J
Tidsskr Nor Laegeforen; 2007 Jun; 127(13):1770-2. PubMed ID: 17599124
[TBL] [Abstract][Full Text] [Related]
2. [General practitioner views on drug-assisted rehabilitation and the Norwegian substance abuse reform].
Aasland OG; Spilhaug G; Johannesen A
Tidsskr Nor Laegeforen; 2009 Jan; 129(2):97-100. PubMed ID: 19151800
[TBL] [Abstract][Full Text] [Related]
3. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
4. [Opiate users in methadone-assisted rehabilitation one year and two years after admission].
Ravndal E; Lauritzen G
Tidsskr Nor Laegeforen; 2004 Feb; 124(3):329-31. PubMed ID: 14963503
[TBL] [Abstract][Full Text] [Related]
5. [General practitioners can take responsibility for medication-based rehabilitation].
Skeie I; Brekke M; Lindbaek M; Waal H
Tidsskr Nor Laegeforen; 2007 Feb; 127(3):296-7. PubMed ID: 17279108
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of opiate addicts in general practice].
Haraldsen M
Tidsskr Nor Laegeforen; 2007 Oct; 127(20):2706-7; author reply 2707. PubMed ID: 17952158
[No Abstract] [Full Text] [Related]
7. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K
J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
[TBL] [Abstract][Full Text] [Related]
8. [Regular prescription of narcotics and sedatives to drug-addicted patients in general practice].
Andersen HT
Tidsskr Nor Laegeforen; 2002 May; 122(12):1202-4. PubMed ID: 12089847
[TBL] [Abstract][Full Text] [Related]
9. Methadone maintenance treatment (MMT) in general practice or in specialized centers: profile of patients in the Swiss Canton of Vaud.
Pelet A; Doll S; Huissoud T; Resplendino J; Besson J; Favrat B
Am J Drug Alcohol Abuse; 2007; 33(5):665-74. PubMed ID: 17891659
[TBL] [Abstract][Full Text] [Related]
10. Mortality prior to, during and after opioid maintenance treatment (OMT): a national prospective cross-registry study.
Clausen T; Anchersen K; Waal H
Drug Alcohol Depend; 2008 Apr; 94(1-3):151-7. PubMed ID: 18155364
[TBL] [Abstract][Full Text] [Related]
11. Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved.
Degenhardt L; Randall D; Hall W; Law M; Butler T; Burns L
Drug Alcohol Depend; 2009 Nov; 105(1-2):9-15. PubMed ID: 19608355
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence.
Ridge G; Gossop M; Lintzeris N; Witton J; Strang J
J Subst Abuse Treat; 2009 Jul; 37(1):95-100. PubMed ID: 19004598
[TBL] [Abstract][Full Text] [Related]
13. Prescribing of pain medication in palliative care. A survey in general practice.
Borgsteede SD; Deliens L; Zuurmond WW; Schellevis FG; Willems DL; Van der Wal G; van Eijk JT
Pharmacoepidemiol Drug Saf; 2009 Jan; 18(1):16-23. PubMed ID: 18985638
[TBL] [Abstract][Full Text] [Related]
14. Do users of regularly prescribed opioids have higher rates of substance use problems than nonusers?
Edlund MJ; Sullivan M; Steffick D; Harris KM; Wells KB
Pain Med; 2007; 8(8):647-56. PubMed ID: 18028043
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia.
Winstock AR; Lea T; Sheridan J
Int J Drug Policy; 2008 Dec; 19(6):450-8. PubMed ID: 18359216
[TBL] [Abstract][Full Text] [Related]
16. Outcomes after intravenous opioids in emergency patients: a prospective cohort analysis.
O'Connor AB; Zwemer FL; Hays DP; Feng C
Acad Emerg Med; 2009 Jun; 16(6):477-87. PubMed ID: 19426295
[TBL] [Abstract][Full Text] [Related]
17. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
Ngo HT; Tait RJ; Hulse GK
Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
[TBL] [Abstract][Full Text] [Related]
18. Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment.
Crettol S; Besson J; Croquette-Krokar M; Hämmig R; Gothuey I; Monnat M; Déglon JJ; Preisig M; Eap CB
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct; 32(7):1722-7. PubMed ID: 18687376
[TBL] [Abstract][Full Text] [Related]
19. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study.
Anchersen K; Clausen T; Gossop M; Hansteen V; Waal H
Addiction; 2009 Jun; 104(6):993-9. PubMed ID: 19392907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
